|
1
|
Kumar SK, Rajkumar V, Kyle RA, van Duin M,
Sonneveld P, Mateos MV, Gay F and Anderson KC: Multiple myeloma.
Nat Rev Dis Primers. 3:170462017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Palumbo A and Anderson K: Multiple
myeloma. N Engl J Med. 364:1046–1060. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rajkumar SV: Multiple myeloma: Every year
a new standard? Hematol Oncol. 37 (Suppl 1):62–65. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raab MS, Podar K, Breitkreutz I,
Richardson PG and Anderson KC: Multiple myeloma. Lancet.
374:324–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Winter G: Aging as disease. Med Health
Care Philos. 18:237–243. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch
SG, Croteau DL and Bohr VA: Ageing as a risk factor for
neurodegenerative disease. Nat Rev Neurol. 15:565–581. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fulop T, Larbi A, Douziech N, Levesque I,
Varin A and Herbein G: Cytokine receptor signalling and aging. Mech
Ageing Dev. 127:526–537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kanagal-Shamanna R, Beck DB and Calvo KR:
Clonal hematopoiesis, inflammation, and hematologic malignancy.
Annu Rev Pathol. 19:479–506. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Urban VS, Cegledi A and Mikala G: Multiple
myeloma, a quintessential malignant disease of aging: A geroscience
perspective on pathogenesis and treatment. Geroscience. 45:727–746.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ullrich F, Bröckelmann PJ, Turki AT, Khan
AM, Chiru ED, Vetter M, Tresckow BV, Wirth R, Cordoba R,
Ortiz-Maldonado V, et al: Impact of immunological aging on T
cell-mediated therapies in older adults with multiple myeloma and
lymphoma. J Immunother Cancer. 12:e0094622024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Visram A and Kourelis TV: Aging-associated
immune system changes in multiple myeloma: The dark side of the
moon. Cancer Treat Res Commun. 29:1004942021.PubMed/NCBI
|
|
12
|
Zweegman S, Palumbo A, Bringhen S and
Sonneveld P: Age and aging in blood disorders: Multiple myeloma.
Haematologica. 99:1133–1137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang B and Zhao S: Polydatin regulates
proliferation, apoptosis and autophagy in multiple myeloma cells
through mTOR/p70s6k pathway. Onco Targets Ther. 10:935–944. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu L, Guo Q, Luo Z, Wang Y, Weng J, Chen
Y, Liang W, Li Y, Zhang Y, Chen K, et al: TXN inhibitor impedes
radioresistance of colorectal cancer cells with decreased ALDH1L2
expression via TXN/NF-κB signaling pathway. Br J Cancer.
127:637–648. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fotiou D, Ntanasis-Stathopoulos I,
Gavriatopoulou M and Dimopoulos MA: Multiple myeloma: Current and
future management in the aging population. Maturitas. 138:8–13.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mafra A, Laversanne M, Marcos-Gragera R,
Chaves HVS, Mcshane C, Bray F and Znaor A: The global multiple
myeloma incidence and mortality burden in 2022 and predictions for
2045. J Natl Cancer Inst. 117:907–914. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Casey M and Nakamura K: The
cancer-immunity cycle in multiple myeloma. Immunotargets Ther.
10:247–260. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo S, Tang Q, Gao X, Hu L, Hu K, Zhang H,
Zhang Q, Lai Y, Liu Y, Wang Z, et al: EZH2 inhibition induces
senescence via ERK1/2 signaling pathway in multiple myeloma. Acta
Biochim Biophys Sin (Shanghai). 56:1055–1064. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wan Y, Wang J, Chen M, Wang J, Nan F,
Huang H, Liu Z and Hou J: Dual roles of IRE1α inhibition in
reversing mitochondrial ROS-induced CD8(+) T-cell senescence and
exerting direct antitumor effects in multiple myeloma. J Immunother
Cancer. 13:e0110442025. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alagpulinsa DA, Szalat RE, Poznansky MC
and Shmookler Reis RJ: Genomic instability in multiple myeloma.
Trends Cancer. 6:858–873. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Plakhova N, Panagopoulos V, Cantley MD,
Trainor LJ, Hewett DR, Clark KC, Gardiner J, Yong A, Lee C, Horvath
N, et al: Age-related mesenchymal stromal cell senescence is
associated with progression from MGUS to multiple myeloma.
Leukemia. 39:1464–1475. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang ZX, Wang YN, Li ZY, Dai ZH, He Y,
Chu K, Gu JY, Ji YX, Sun NX, Yang F and Li W: The m6A mRNA
demethylase FTO in granulosa cells retards FOS-dependent ovarian
aging. Cell Death Dis. 12:7442021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abdul Sani NF, Amir Hamzah AIZ, Abu Bakar
ZH, Mohd Yusof YA, Makpol S, Wan Ngah WZ and Damanhuri HA: Gene
expression profile in different age groups and its association with
cognitive function in healthy malay adults in Malaysia. Cells.
10:16112021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Wang J, Shen K and Jin W:
p53/HIF-1α regulates neuronal aging and autophagy in spinal cord
ischemia/reperfusion injury. Mech Ageing Dev. 222:1120002024.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salazar G, Cullen A, Huang J, Zhao Y,
Serino A, Hilenski L, Patrushev N, Forouzandeh F and Hwang HS:
SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy
and vascular senescence. Autophagy. 16:1092–1110. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen K, Qin C, Ji C, Yu Y, Wu Y, Xu L,
Jiang Y and Zou G: Astragalus polysaccharide alleviates oxidative
stress and senescence in chondrocytes in osteoarthritis via
GCN2/ATF4/TXN axis. Int J Biol Macromol. 310((Pt 3)): 1432852025.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hernandez-Segura A, Nehme J and Demaria M:
Hallmarks of Cellular Senescence. Trends Cell Biol. 2018.28.
436–453. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matthews GM, de Matos Simoes R, Dhimolea
E, Sheffer M, Gandolfi S, Dashevsky O, Sorrell JD and Mitsiades CS:
NF-κB dysregulation in multiple myeloma. Semin Cancer Biol.
39:68–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
